Research Article

Peripheral Arterial Disease in Type 2 Diabetes Is Associated with an Increase in Fibrinogen Levels

Table 1

Baseline characteristics between subjects with and without PAD.

Non-PAD ()PAD () value

Male no. (%)89 (42.6%)385 (43.4%)0.830
Age62.49 ± 11.7063.4 ± 11.090.294
Smoking (%)62 (29.7%)287 (32.4%)0.453
Alcohol use (%)54 (25.8%)197 (22.2%)0.036
Diabetes duration (months)115.57 ± 85.03112.35 ± 81.940.612
Stroke (%)77 (36.8%)357 (40.2%)0.362
Hypertension (%)91 (43.5%)599 (67.5%)<0.001
Weight (kg)65.78 ± 12.1964.22 ± 11.090.073
Height (cm)162.24 ± 8.57161.97 ± 8.400.676
BMI (kg/m2)24.90 ± 3.6424.38 ± 3.430.053
Waist circumference (cm)91.88 ± 11.9090.04 ± 10.410.026
Hip circumference (cm)96.14 ± 8.8794.87 ± 9.190.072
Waist/hip ratio0.95 ± 0.070.96 ± 0.290.879
Fibrinogen (g/L)3.52 ± 1.204.06 ± 1.39<0.001
TC (mmol/L)4.85 ± 2.554.65 ± 1.360.115
TG (mmol/L)1.80 ± 1.391.81 ± 1.510.928
HDL-C (mmol/L)1.15 ± 0.371.06 ± 0.30<0.001
LDL-C (mmol/L)2.71 ± 0.942.71 ± 1.020.986
HbA1c (%)9.41 ± 2.249.14 ± 2.210.114

PAD: peripheral arterial disease; BMI: body mass index; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein-cholesterol.